Related Experiment Video
Updated: Dec 31, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Atrial fibrillation: is there a role for cardiac troponin?
Alireza Sepehri Shamloo1, Arash Arya1, Angeliki Darma1
1Department of Electrophysiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany.
Insights
Atrial fibrillation (AF) is a common heart rhythm disorder. This review explores how cardiac-specific troponin levels may help manage AF patients, despite current guideline limitations.
Area of Science:
- Cardiology
- Biomarker Research
Background:
- Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia.
- AF prevalence is projected to double in coming decades.
- Biomarker use in AF management lags behind other cardiac conditions.
Purpose of the Study:
- To review the association between cardiac-specific troponin and AF.
- To propose clinical applications for troponin in AF patient management.
Main Methods:
- Literature review of studies investigating troponin and AF.
- Analysis of existing evidence on troponin's role in AF risk and complications.
Main Results:
- Growing evidence links higher cardiac-specific troponin levels to increased risk of incident and recurrent AF.
- Troponin may also be associated with AF complications.
Conclusions:
- Cardiac-specific troponin shows potential as a biomarker in AF management.
- Clinical guidelines should consider incorporating troponin for AF patient care.
Abstract:
Atrial fibrillation (AF) is the most common sustained arrhythmia, and its prevalence rate is expected to be doubled over the next decades. Despite the wide use of biomarkers in the management of different cardiac diseases such as myocardial infarction and heart failure, utilization of biomarkers in AF management is not routinely recommended by current guidelines. There is also growing evidence that higher levels of cardiac-specific troponin, as an intracellular protein involved in cardiomyocyte contraction, may be associated with the risk of incident and recurrent AF and its complications. In the present paper, we review the association between troponin and AF and propose clinical suggestions for use of troponin in the management of AF patients.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Dysrhythmias V: Evaluating Dysrhythmias
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Mechanism of Cardiac Arrhythmias

